Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) — Capital Reinvestment Ratio
Eckert & Ziegler Strahlen- und Medizintechnik AG (EUZ) has a Capital Reinvestment Ratio of 0.46x as of December 2025, meaning it reinvests 0% of its operating cash flow (€18.75 Million) in capital expenditures (€8.70 Million). See EUZ equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Eckert & Ziegler Strahlen- und Medizintechnik AG Capital Reinvestment Ratio (2013–2025)
This chart tracks Eckert & Ziegler Strahlen- und Medizintechnik AG's Capital Reinvestment Ratio across 13 annual periods. Check EUZ cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Eckert & Ziegler Strahlen- und Medizintechnik AG (2013–2025)
Year-by-year Capital Reinvestment Ratio for Eckert & Ziegler Strahlen- und Medizintechnik AG from 2013 to 2025. For live market cap and broader valuation context, see EUZ market cap.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.45x | €58.41 Million | €26.02 Million | ▲ +72.5% |
| 2024 | 0.26x | €66.57 Million | €17.19 Million | ▼ -53.4% |
| 2023 | 0.55x | €47.40 Million | €26.28 Million | ▼ -38.9% |
| 2022 | 0.91x | €34.30 Million | €31.13 Million | ▲ +6.5% |
| 2021 | 0.85x | €33.85 Million | €28.86 Million | ▲ +321.6% |
| 2020 | 0.20x | €34.95 Million | €7.07 Million | ▲ +12.7% |
| 2019 | 0.18x | €40.43 Million | €7.25 Million | ▼ -37.8% |
| 2018 | 0.29x | €21.21 Million | €6.12 Million | ▲ +86.2% |
| 2017 | 0.16x | €26.83 Million | €4.16 Million | ▼ -42.3% |
| 2016 | 0.27x | €19.83 Million | €5.33 Million | ▲ +13.5% |
| 2015 | 0.24x | €16.23 Million | €3.84 Million | ▼ -67.7% |
| 2014 | 0.73x | €10.65 Million | €7.82 Million | ▲ +11.6% |
| 2013 | 0.66x | €14.68 Million | €9.65 Million | — |